ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

CIK: 0002054410 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: May 19, 2025

Total Value ($000): $185,821 (100.0% shares, 0.0% debt)

Holdings (21)

CGON CG ONCOLOGY INC 17.5%

Value ($000) $32,451 Shares 1,131,501 Est. Cost $34.21 Unrealized 0.0%

— Y-MABS THERAPEUTICS INC 12.1%

Value ($000) $22,408 Shares 2,861,825 Est. Cost $7.83 Unrealized —

CADL CANDEL THERAPEUTICS INC 9.1%

Value ($000) $16,836 Shares 1,939,644 Est. Cost $5.91 Unrealized 0.0%

URGN UROGEN PHARMA LTD 8.7%

Value ($000) $16,149 Shares 1,516,303 Est. Cost $11.97 Unrealized 0.0%

PBYI PUMA BIOTECHNOLOGY INC 6.5%

Value ($000) $12,017 Shares 3,940,052 Est. Cost $2.91 Unrealized 0.0%

BCAX BICARA THERAPEUTICS 6.0%

Value ($000) $11,208 Shares 643,381 Est. Cost $20.81 Unrealized 0.0%

TERN TERNS PHARMACEUTICALS INC 5.9%

Value ($000) $10,921 Shares 1,971,264 Est. Cost $6.77 Unrealized 0.0%

OKUR ONKURE THERAPEUTICS INC 5.5%

Value ($000) $10,248 Shares 1,439,674 Est. Cost $15.14 Unrealized 0.0%

TRVI TREVI THERAPEUTICS INC 4.4%

Value ($000) $8,244 Shares 2,001,048 Est. Cost $3.20 Unrealized 0.0%

TARA PROTARA THERAPEUTICS INC 3.6%

Value ($000) $6,757 Shares 1,279,800 Est. Cost $3.23 Unrealized 0.0%

HELP CYBIN INC 3.5%

Value ($000) $6,477 Shares 734,393 Est. Cost $10.16 Unrealized 0.0%

CRDF CARDIF ONCOLOGY INC 3.4%

Value ($000) $6,260 Shares 1,442,308 Est. Cost $3.13 Unrealized 0.0%

— X4 PHARMACEUTICALS INC 2.9%

Value ($000) $5,363 Shares 7,310,650 Est. Cost $0.73 Unrealized —

— MURAL ONCOLOGY PLC 2.2%

Value ($000) $4,141 Shares 1,286,079 Est. Cost $3.22 Unrealized —

WHWK AADI BIOSCIENCE INC 1.9%

Value ($000) $3,619 Shares 1,147,052 Est. Cost $2.27 Unrealized 0.0%

— OPTINOSE INC 1.5%

Value ($000) $2,824 Shares 422,813 Est. Cost $6.68 Unrealized —

QTTB Q32 BIO INC. 1.5%

Value ($000) $2,764 Shares 803,425 Est. Cost $31.58 Unrealized 0.0%

ACRV ACRIVON THERAPEUTICS INC 1.3%

Value ($000) $2,440 Shares 405,237 Est. Cost $7.27 Unrealized 0.0%

BCAB BIOATLA INC 1.3%

Value ($000) $2,384 Shares 4,032,046 Est. Cost $1.68 Unrealized 0.0%

VYNE VYNE THERAPEUTICS INC 0.8%

Value ($000) $1,531 Shares 456,970 Est. Cost $2.62 Unrealized 0.0%

VSTM VERASTEM INC 0.4%

Value ($000) $779 Shares 779,498 Est. Cost $3.94 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	1,131,501	$32,451	17.5%	$34.21	0.0%	COM	156944100
—	Y-MABS THERAPEUTICS INC	2,861,825	$22,408	12.1%	$7.83	—	COM	984241109
CADL	CANDEL THERAPEUTICS INC	1,939,644	$16,836	9.1%	$5.91	0.0%	COM	137404109
URGN	UROGEN PHARMA LTD	1,516,303	$16,149	8.7%	$11.97	0.0%	COM	M96088105
PBYI	PUMA BIOTECHNOLOGY INC	3,940,052	$12,017	6.5%	$2.91	0.0%	COM	74587V107
BCAX	BICARA THERAPEUTICS	643,381	$11,208	6.0%	$20.81	0.0%	COM	055477103
TERN	TERNS PHARMACEUTICALS INC	1,971,264	$10,921	5.9%	$6.77	0.0%	COM	880881107
OKUR	ONKURE THERAPEUTICS INC	1,439,674	$10,248	5.5%	$15.14	0.0%	CLASS A COM	68277Q105
TRVI	TREVI THERAPEUTICS INC	2,001,048	$8,244	4.4%	$3.20	0.0%	COM	89532M101
TARA	PROTARA THERAPEUTICS INC	1,279,800	$6,757	3.6%	$3.23	0.0%	COM STK	74365U107
HELP	CYBIN INC	734,393	$6,477	3.5%	$10.16	0.0%	COM NEW	23256X407
CRDF	CARDIF ONCOLOGY INC	1,442,308	$6,260	3.4%	$3.13	0.0%	COM	14147L108
—	X4 PHARMACEUTICALS INC	7,310,650	$5,363	2.9%	$0.73	—	COM	98420X103
—	MURAL ONCOLOGY PLC	1,286,079	$4,141	2.2%	$3.22	—	COM	G63365103
WHWK	AADI BIOSCIENCE INC	1,147,052	$3,619	1.9%	$2.27	0.0%	COM	00032Q104
—	OPTINOSE INC	422,813	$2,824	1.5%	$6.68	—	COM NEW	68404V209
QTTB	Q32 BIO INC.	803,425	$2,764	1.5%	$31.58	0.0%	COM	746964105
ACRV	ACRIVON THERAPEUTICS INC	405,237	$2,440	1.3%	$7.27	0.0%	COMMON STOCK	004890109
BCAB	BIOATLA INC	4,032,046	$2,384	1.3%	$1.68	0.0%	COM	09077B104
VYNE	VYNE THERAPEUTICS INC	456,970	$1,531	0.8%	$2.62	0.0%	COM	92941V308
VSTM	VERASTEM INC	779,498	$779	0.4%	$3.94	0.0%	COM NEW	92337C203